The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More

Media Database M moneycontrol.com Viswanath Pilla

Viswanath Pilla
viswanath_pilla

1041 followers

Mumbai, India

Journalist @moneycontrolcom. Tracks pharma/healthcare. Previously @EconomicTimes @livemint @CNBCTV18Live. Views are personal, RTs are not endorsements.

Publications:
Topics
biocon biologics, biosimilars, cell and gene therapy, diabetes, eli lilly, generic drugs, glp-1, mounjaro, novo nordisk, obesity, ozempic, q4 earnings, q4fy25 earnings, trump tariffs, wegovy, weight loss, weight loss drugs, apollo hospitals, biocon, mounjaro, semaglutide
Recent articles
Biocon posts Rs 31 crore net profit in Q1FY26
Aug 07, 2025
moneycontrol.com
Trump's tariff threats: Indian Pharma is ready with a multi-pronged defence strategy
Aug 07, 2025
moneycontrol.com
SCHOTT expands India footprint with first local production of syringe and cartridge glass tubing
Aug 07, 2025
moneycontrol.com
Indian pharma dodges Trump’s additional 25% tariff for now
Aug 06, 2025
moneycontrol.com
Alembic Pharma’s June quarter profit grows 25 percent on strong US generics sales
Aug 05, 2025
moneycontrol.com
Pharma giant Eli Lilly opens strategic technology and innovation hub in Hyderabad
Aug 04, 2025
moneycontrol.com
Indian pharma exports not part of Trump's 25% tariff ambit
Jul 31, 2025
moneycontrol.com
Mankind Pharma net drops 17.4% YoY to Rs 445 crore in Q1FY26
Jul 31, 2025
moneycontrol.com
Abbott India reboots Digene: old-school antacid, new school vibe
Jul 30, 2025
moneycontrol.com
Dr Reddy's prioritises branded assets for strategic acquisitions: CFO Narasimham
Jul 28, 2025
moneycontrol.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account